exRNA Atlas Analysis Reveals Distinct Extracellular RNA Cargo Types and Their Carriers Present across Human Biofluids
- PMID: 30951672
- PMCID: PMC6616370
- DOI: 10.1016/j.cell.2019.02.018
exRNA Atlas Analysis Reveals Distinct Extracellular RNA Cargo Types and Their Carriers Present across Human Biofluids
Abstract
To develop a map of cell-cell communication mediated by extracellular RNA (exRNA), the NIH Extracellular RNA Communication Consortium created the exRNA Atlas resource (https://exrna-atlas.org). The Atlas version 4P1 hosts 5,309 exRNA-seq and exRNA qPCR profiles from 19 studies and a suite of analysis and visualization tools. To analyze variation between profiles, we apply computational deconvolution. The analysis leads to a model with six exRNA cargo types (CT1, CT2, CT3A, CT3B, CT3C, CT4), each detectable in multiple biofluids (serum, plasma, CSF, saliva, urine). Five of the cargo types associate with known vesicular and non-vesicular (lipoprotein and ribonucleoprotein) exRNA carriers. To validate utility of this model, we re-analyze an exercise response study by deconvolution to identify physiologically relevant response pathways that were not detected previously. To enable wide application of this model, as part of the exRNA Atlas resource, we provide tools for deconvolution and analysis of user-provided case-control studies.
Keywords: ERCC; deconvolution; exRNA; exosomes; extracellular RNA; extracellular vesicles; lipoproteins; ribonucleoproteins.
Copyright © 2019 Elsevier Inc. All rights reserved.
Figures







Comment in
-
Mapping Extracellular RNA Sheds Lights on Distinct Carriers.Cell. 2019 Apr 4;177(2):228-230. doi: 10.1016/j.cell.2019.03.027. Cell. 2019. PMID: 30951666
References
-
- Abdi H, and Williams LJ (2010). Principal component analysis. Wiley interdisciplinary reviews: computational statistics 2(4), 433–459.
-
- Burgos K, Malenica I, Metpally R, Courtright A, Rakela B, Beach T, Shill H, Adler C, Sabbagh M, Villa S, and Tembe W (2014). Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer’s and Parkinson’s diseases correlate with disease status and features of pathology. PloS one 9(5), p.e94839. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AG059729/AG/NIA NIH HHS/United States
- R01 HL122547/HL/NHLBI NIH HHS/United States
- P30 DK063720/DK/NIDDK NIH HHS/United States
- UH3 TR000906/TR/NCATS NIH HHS/United States
- P50 CA217685/CA/NCI NIH HHS/United States
- UH2 TR000906/TR/NCATS NIH HHS/United States
- R35 CA209904/CA/NCI NIH HHS/United States
- UH2 TR000923/TR/NCATS NIH HHS/United States
- UH3 TR000943/TR/NCATS NIH HHS/United States
- U54 DA036134/DA/NIDA NIH HHS/United States
- UH3 TR000891/TR/NCATS NIH HHS/United States
- UH3 TR000901/TR/NCATS NIH HHS/United States
- UH3 TR000923/TR/NCATS NIH HHS/United States
- UH2 TR000901/TR/NCATS NIH HHS/United States
- K23 HL127099/HL/NHLBI NIH HHS/United States
- R01 HL133575/HL/NHLBI NIH HHS/United States
- R25 GM056929/GM/NIGMS NIH HHS/United States
- R01 HL136685/HL/NHLBI NIH HHS/United States
- U19 CA179512/CA/NCI NIH HHS/United States
- T32 GM008307/GM/NIGMS NIH HHS/United States
- U01 HL126494/HL/NHLBI NIH HHS/United States
- R01 CA163849/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases